Corporate News

Exercise of Options

23 December 2024

MyHealthChecked PLC (AIM: MHC), the consumer home-testing healthcare company, announces that the Company has received a request to exercise options over 30,000 ordinary shares of 1.5p each in the Company. The request has been satisfied by the allotment on 20 December 2024 of new ordinary shares issued under the Company's allotment authorities.

The New Ordinary Shares rank pari passu in all respects with the Company's existing Ordinary Shares. An application will be made to the London Stock Exchange for the 30,000 New Ordinary Shares (the "New Ordinary Shares") to be admitted to trading on AIM ("Admission"). Admission is expected to occur at 8.00am on or around 31 December 2024.

The options, the subject of the request, had an exercise price of 9.5 pence per share.

Admission of shares and total voting rights

Following Admission, the total issued share capital of the Company will consist of 52,035,932 ordinary shares.  As each ordinary share carries the right to one vote, the total number of voting rights in the Company will be 52,035,932.  This number may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

For further information contact:

 

MyHealthChecked plc

www.myhealthchecked.com

Penny McCormick, Chief Executive Officer

via Walbrook PR




SPARK Advisory Partners Limited (NOMAD)

Tel: +44 (0)20 3368 3550

Neil Baldwin / Jade Bayat







Dowgate Capital Limited (Broker)

Tel: +44 (0)20 3903 7715

David Poutney / Nicholas Chambers






Walbrook PR Ltd (Media & IR)

Tel: +44 (0)20 7933 8780 or [email protected]

Paul McManus / Alice Woodings

Mob: +44 (0)7980 541 893 / +44(0)7407 804 654

 

About MyHealthChecked PLC (www.myhealthcheckedplc.com)

MyHealthChecked PLC, based in Cardiff, is an AIM-quoted pioneering UK healthcare company focused on a range of at-home healthcare and wellness tests.

MyHealthChecked is the umbrella brand of a range of at-home rapid tests, as well as DNA, RNA and blood sample collection kits which have been created to support customers on their journeys to wellness. The tests are lateral-flow self-tests, whilst the sample collection kits enable the collection of blood, urine, nasal or mouth swab samples that are analysed in partner laboratories for a range of biomarkers. The tests have been made available online and for over-the-counter purchase. 

The MyHealthChecked portfolio has been identified as part of a change in mindset as customers become more familiar with the concept of accessible healthcare in the growing at home testing kit market with a focus on accessibility at the right price, led by UK-based experts.